Project Grant HT94252311005
Award Date
9/15/23
Completion Date
9/14/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
The University of Southern California was awarded a $1,992,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from September 15, 2025 to September 14, 2028, will support research on a synthetic immune receptor for the treatment of prostate cancer. This advanced biomedical research project aims to transform healthcare for military service members and the broader public...
The University of Southern California will receive $413,750 through September 2025 under a Project Grant from the Defense Health Agency to develop next-generation chimeric antigen receptor T cells targeting folate receptor 1 for the treatment of ovarian cancer. Funded through the Military Medical Research and Development program (CFDA 12.420), this award will support the grantee's applied medical research efforts to investigate innovative solutions for battlefield health care and transform...
The University of Southern California (USC) was awarded a $915,936 Project Grant from the U.S. Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research to investigate SETD2 deficiency as a therapeutic target to upregulate viral mimicry for treating aggressive clear cell renal cell carcinoma in patients. This award is part of the program's focus on cancer, neurological disorders, and other health...
The University of Southern California will receive $165,000 under a Project Grant award from the Defense Health Agency to investigate using WEE1 inhibitor to convert immune cold tumors into immune hot tumors for aggressive clear cell renal cell carcinoma with SETD2 deficiency. The grant period runs from April 1, 2023 to March 31, 2024. This award falls under the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to...
The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...
The Department of Defense awarded a $3,166,177 Cooperative Agreement to the University of Southern California (USC) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2023. This funding supports the "Convergent Science Cancer Consortium" project, which aims to transform healthcare for Service Members and the American public through innovative biomedical research on cancer and other disease areas. As part of this effort, USC has sub-awarded...
The University of Southern California (USC) was awarded a $3,296,634.00 Project Grant from the Defense Health Agency to conduct research on "ACTIVATION OF BRAIN LYMPHATIC DRAINAGE THROUGH PIEZO1-CONTROLLED MECHANOTRANSDUCTION AS A NOVEL HYDROCEPHALUS THERAPY". The grant, which commenced on September 1, 2023 and will be completed by August 31, 2027, is funded through the Military Medical Research and Development (CFDA 12.420) program. This research aims to investigate medical...
The University of Southern California (USC) received a $828,538 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MICRORNA THERAPY TARGETING FIBROTIC SCAR FORMATION FOR IMPROVEMENT OF COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY". The award has a performance period from May 1, 2024 to April 30, 2027. The funded research aims to develop novel microRNA-based therapies to address fibrotic...
This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...
The University of Southern California will receive $1,055,681 under a four-year Cooperative Agreement from the Defense Health Agency to develop a Convergent Science Virtual Cancer Center. The award, made on September 15, 2021 under the Military Medical Research and Development program (CFDA 12.420), will support the transformation of health care for Service Members and the public through innovative cancer research. Through this funding, USC will investigate medical solutions for battlefield...